Integra Lifesciences Holdings Corp  

(Public, NASDAQ:IART)   Watch this stock  
Find more results for IART
36.40
-0.11 (-0.30%)
May 24 - Close
NASDAQ real-time data - Disclaimer
Currency in USD
Range 36.04 - 36.59
52 week 30.87 - 44.53
Open 36.32
Vol / Avg. 94,893.00/288,821.00
Mkt cap 1.02B
P/E 34.19
Div/yield     -
EPS 1.06
Shares 28.06M
Beta 0.90
Inst. own 73%
Jul 22, 2013
Q2 2013 Integra LifeSciences Corporation Earnings Release Add to calendar
May 30, 2013
Integra LifeSciences Corporation at Deutsche Bank dbAccess Health Care Conference - 11:20AM EDT - Add to calendar
May 22, 2013
Integra LifeSciences Corporation Annual Shareholder Meeting
May 21, 2013
Integra LifeSciences Corporation at UBS Global Healthcare Conference
May 14, 2013
Integra LifeSciences Corporation at Bank of America Merrill Lynch Health Care Conference
May 2, 2013
Q1 2013 Integra LifeSciences Corporation Earnings Conference Call
Apr 22, 2013
Q1 2013 Integra LifeSciences Corporation Earnings Release
Mar 19, 2013
Integra LifeSciences Corporation at Canaccord Genuity Musculoskeletal Conference
Mar 12, 2013
Integra LifeSciences Corporation at Barclays Healthcare Conference
Feb 26, 2013
Integra LifeSciences Corporation at Citi Global Healthcare Conference
More events from DailyFinance »    

Key stats and ratios

Q1 (Mar '13) 2012
Net profit margin -2.06% 4.96%
Operating margin -0.02% 8.88%
EBITD margin - 23.03%
Return on average assets -1.40% 3.57%
Return on average equity -3.16% 8.16%
Employees 3,500 -
Carbon Disclosure Rating - -

Address

311 Enterprise Drive
PLAINSBORO, NJ 08536
United States - Map
+1-609-2750500 (Phone)
+1-609-2755363 (Fax)

Website links

External links

Analyst Estimates - MarketWatch
SEC Filings - EDGAR Online
Major Holders - MSN Money
Discussion Group - Google Finance

Description

Integra LifeSciences Holdings Corporation (Integra) is an integrated medical technology company. Integra offers solutions in orthopedic extremity surgery, neurosurgery, spine surgery, and reconstructive and general surgery. The Company has developed numerous product lines for applications ranging from burn and deep tissue wounds to regeneration of dura mater in the brain and repair of nerve and tendon. It operates in five business segments: U.S. Neurosurgery, U.S. Extremities, U.S. Instruments, U.S. Spine and Other, and International. The International segment sells similar products to Europe, Middle East and Africa, and Central/South America, Asia-Pacific and Canada. On April 29, 2013, the Company launched the Integra Compact Cranial Closure System, which provides titanium implants for non-loadbearing (non-facial) operative cranial neurosurgical procedures. On April 30, 2013, it released its Hollywood VI intervertebral body fusion device (IBD) system.

Officers and directors

Stuart M. Essig Ph.D. Chairman of the Board
Age: 51
Bio & Compensation  - Reuters
Peter J. Arduini President, Chief Executive Officer, Director
Age: 48
Bio & Compensation  - Reuters
John B. Henneman III Corporate Vice President - Finance and Administration, Chief Financial Officer
Age: 51
Bio & Compensation  - Reuters
Padma Thiruvengadam Chief Human Resources Officer, Corporate Vice President
Age: 48
Bio & Compensation  - Reuters
Judith E. O'Grady Corporate Vice President - Global Regulatory Affairs, Corporate Compliance Officer
Age: 62
Bio & Compensation  - Reuters
John Mooradian Corporate Vice President - Global Operations and Supply Chain
Age: 57
Bio & Compensation  - Reuters
Jerry E. Corbin Corporate Vice President, Principal Accounting Officer, Corporate Controller
Age: 53
Bio & Compensation  - Reuters
Richard D. Gorelick Corporate Vice President, General Counsel, Administration, Secretary
Age: 52
Bio & Compensation  - Reuters
Robert T. Davis Jr. Corporate Vice President, President - Neurosurgery
Age: 54
Bio & Compensation  - Reuters
Brian Larkin Corporate Vice President, President - Global Spine and Orthobiologics, and Head of Strategic Development
Age: 44
Bio & Compensation  - Reuters